Valuation Strides Pharma Science Limited

Stocks

Market Closed - NSE India S.E. 16:22:05 30/10/2026 +04			5-day change	1st Jan Change
1,068.80 ^INR	-2.62%		+5.32%	+18.71%

10-30	Strides Pharma Science Limited, Q2 2027 Earnings Call, Oct 30, 2026
10-30	Strides Pharma Science Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	31,121	25,858	72,114	61,675	86,435	98,514	-
Change	-	-16.91%	178.88%	-14.47%	40.15%	13.97%	-
Enterprise Value (EV)	31,121	25,858	72,114	61,675	86,435	98,514	98,514
Change	-	-16.91%	178.88%	-14.47%	40.15%	13.97%	0%
P/E	-6.76x	-12.7x	-101x	1.71x	15.5x	15.7x	11.2x
PBR	1.32x	1.19x	3.39x	-	2.78x	2.66x	2.19x
PEG	-	0.2x	1.5x	-0x	-0.2x	1.2x	0.3x
Capitalization / Revenue	1.01x	0.7x	1.78x	1.35x	1.78x	1.69x	1.43x
EV / Revenue	0x	0x	0x	0x	0x	1.69x	1.43x
EV / EBITDA	-0x	0x	0x	0x	0x	8.82x	7.03x
EV / EBIT	-0x	0x	0x	-	0x	11.1x	9x
EV / FCF	-0x	-0x	0x	0x	0x	20.5x	15x
FCF Yield	-12.9%	-1.95%	8.08%	7.16%	3.29%	4.88%	6.66%
Dividend per Share ²	-	1.5	2.5	-	5	3	3
Rate of return	-	0.52%	0.32%	-	0.53%	0.28%	0.28%
EPS ²	-51.28	-22.49	-7.76	390.5	60.34	68.1	95.4
Distribution rate	-	-6.67%	-32.2%	-	8.29%	4.41%	3.14%
Net sales ¹	30,702	36,884	40,511	45,653	48,587	58,230	69,123
EBITDA ¹	-103.2	4,302	7,433	8,028	9,253	11,173	14,014
EBIT ¹	-2,531	1,869	5,226	-	7,229	8,850	10,940
Net income ¹	-4,602	-2,026	-706.1	35,935	5,562	6,277	8,798
Net Debt	-	-	-	-	-	-	-
Reference price ²	346.60	286.35	784.70	669.20	937.75	1,068.80	1,068.80
Nbr of stocks (in thousands)	89,790	90,303	91,900	92,163	92,173	92,173	-
Announcement Date	24/05/22	25/05/23	22/05/24	22/05/25	18/05/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
STRIDES PHARMA SCIENCE LIMITED	15.69x	-	-	0.28%	1.04B
ELI LILLY AND COMPANY	41.42x	14.04x	31.11x	0.48%	1,263B
JOHNSON & JOHNSON	39.99x	6.71x	18.89x	1.95%	658B
ABBVIE INC.	36.71x	8.6x	17.71x	2.33%	521B
ROCHE HOLDING AG	21.74x	5.27x	13.12x	2.48%	391B
MERCK & CO., INC.	106.24x	6.06x	25.8x	2.28%	369B
NOVARTIS AG	23.19x	5.95x	14.36x	2.69%	307B
ASTRAZENECA PLC	24.47x	4.89x	13.59x	1.77%	290B
AMGEN INC.	29.55x	7.53x	13.48x	2.16%	252B
GILEAD SCIENCES, INC.	-41.18x	7.46x	46.76x	1.93%	212B
Average	29.78x	7.39x	21.65x	1.84%	426.3B
Weighted average by Cap.	37.15x	8.83x	22.81x	1.69%